Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Hammond

Showing results (491-500 of 555) with videos related to

Pageof 56
Sort By:
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
The Third Intergroup Rhabdomyosarcoma StudyW Crist, E A Gehan, A H Ragab, et al.
The American Journal of Pediatric Hematology/Oncology|November 1, 1992
A phase I study of interleukin-2 in children with cancerM Roper, M A Smith, P M Sondel, et al.
Blood|May 1, 1992
Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significanceF O Smith, B C Lampkin, C Versteeg, et al.
Medical and Pediatric Oncology|January 1, 1992
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study GroupP A Dinndorf, J D Buckley, M E Nesbit, et al.
Journal of Pediatric Surgery|February 1, 1988
The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study GroupJ T Makley, M Krailo, I J Ertel, et al.
Cancer Research|September 15, 1991
Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study GroupR Patel, E M Newman, D G Villacorte, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
Pageof 56

Showing results (491-500 of 555) with videos related to

Sort By:
Pageof 56
Lancet (London, England)|June 28, 1980
Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemiaD M Green, A I Freeman, H N Sather, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1995
The Third Intergroup Rhabdomyosarcoma StudyW Crist, E A Gehan, A H Ragab, et al.
The American Journal of Pediatric Hematology/Oncology|November 1, 1992
A phase I study of interleukin-2 in children with cancerM Roper, M A Smith, P M Sondel, et al.
Blood|May 1, 1992
Expression of lymphoid-associated cell surface antigens by childhood acute myeloid leukemia cells lacks prognostic significanceF O Smith, B C Lampkin, C Versteeg, et al.
Medical and Pediatric Oncology|January 1, 1992
Expression of myeloid differentiation antigens in acute nonlymphocytic leukemia: increased concentration of CD33 antigen predicts poor outcome--a report from the Childrens Cancer Study GroupP A Dinndorf, J D Buckley, M E Nesbit, et al.
Journal of Pediatric Surgery|February 1, 1988
The relationship of various aspects of surgical management to outcome in childhood nonmetastatic osteosarcoma: a report from the Childrens Cancer Study GroupJ T Makley, M Krailo, I J Ertel, et al.
Cancer Research|September 15, 1991
Pharmacology and phase I trial of high-dose oral leucovorin plus 5-fluorouracil in children with refractory cancer: a report from the Children's Cancer Study GroupR Patel, E M Newman, D G Villacorte, et al.
Lancet (London, England)|February 9, 1991
Do children benefit from mass screening for neuroblastoma? Consensus Statement from the American Cancer Society Workshop on Neuroblastoma ScreeningS B Murphy, S L Cohn, A W Craft, et al.
Cancer Research|March 1, 1993
Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusionS M Blaney, F M Balis, D E Cole, et al.
Cancer Treatment Reports|November 1, 1987
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapyG H Reaman, P G Steinherz, P S Gaynon, et al.
Pageof 56